摘要
银屑病是一种免疫介导的慢性炎症性皮肤病,目前认为银屑病的发病机制可能与遗传、免疫、药物、环境、心理等因素相关。银屑病不仅给患者生活带来了极大的影响,也加重了社会医疗的负担。在银屑病的治疗中,生物制剂作为新型的治疗方法展现了良好的治疗效果,但限于各种因素,传统药物治疗依然是银屑病治疗的重要部分。本文将银屑病治疗中的系统用药和外用药物内容进行综述,期望给临床医生提供参考。
Psoriasis is an immune-mediated chronic inflammatory skin disease,which is currently thought to be linked with various factors,such as genetics,immunity,drugs,environment and psychology.Psoriasis not only brings great impact to the patients'lives,but also imposes a significant burden on society and healthcare.Although biologics have emerged as a promising treatment for psoriasis,conventional treatments still play a critical role in managing the disease.This article will provide clinical references with an overview of the systemic and topical drugs in the treatment of psoriasis.
作者
葛李洋
林世颖
陈宏翔
Ge Liyang;Lin Shiying;Chen Hongxiang(Department of Dermatology,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430000,Hubei China;Department of Dermatology,Huazhong University of Science and Technology Union Shenzhen Hospital,Shenzhen 518052,Guangdong China)
出处
《中国医学前沿杂志（电子版）》
CSCD
2023年第5期19-24,共6页
Chinese Journal of the Frontiers of Medical Science(Electronic Version)
基金
国家自然科学基金(81974475,82173423)
深圳市基础研究专项(自然科学基金)基础研究面上项目(JCYJ20190809103805589)
深圳市南山区科技计划项目/重点项目(2019003)。
关键词
银屑病
治疗
系统用药
外用药
Psoriasis
Drug therapy
Intravenous
Topical
Cutaneous
